Abstract
In order to identify a transcription component of programmed cell death (PCD), this review compiles and cross-compares genome-scale gene expression analyses of several models of apoptosis. Large-scale transcription profiling studies to date have utilized diverse technologies such as cDNA arrays and serial analysis of gene expression (SAGE). Despite the varying technology platforms, commonly regulated genes were identified and fell into three major categories those related to the regulation of cell cycle, inflammatory responses, and oxidative stress. The observation that common markers were regulated across different models of apoptosis demonstrates the utility of genome-scale gene expression analysis for cell death pathway mining.
Keywords: Apoptosis, Arrays, Programmed Cell Death, serial analysis of gene expression sage, Validation
Current Genomics
Title: Apoptosis and Arrays: Identifying a Transcription Component of Programmed Cell Death
Volume: 3 Issue: 1
Author(s): Lillian W. Chiang
Affiliation:
Keywords: Apoptosis, Arrays, Programmed Cell Death, serial analysis of gene expression sage, Validation
Abstract: In order to identify a transcription component of programmed cell death (PCD), this review compiles and cross-compares genome-scale gene expression analyses of several models of apoptosis. Large-scale transcription profiling studies to date have utilized diverse technologies such as cDNA arrays and serial analysis of gene expression (SAGE). Despite the varying technology platforms, commonly regulated genes were identified and fell into three major categories those related to the regulation of cell cycle, inflammatory responses, and oxidative stress. The observation that common markers were regulated across different models of apoptosis demonstrates the utility of genome-scale gene expression analysis for cell death pathway mining.
Export Options
About this article
Cite this article as:
Chiang W. Lillian, Apoptosis and Arrays: Identifying a Transcription Component of Programmed Cell Death, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350624
DOI https://dx.doi.org/10.2174/1389202023350624 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy Chemotherapy with si-RNA and Anti-Cancer Drugs
Current Drug Delivery Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Current Medicinal Chemistry New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Current Medicinal Chemistry - Anti-Cancer Agents Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors
Current Medicinal Chemistry Chronic Myelogenous Leukemia
Current Cancer Therapy Reviews CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
Current Pharmaceutical Design Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses
Current Pharmaceutical Biotechnology Translational Research of Photodynamic Therapy with Acridine Orange which Targets Cancer Acidity
Current Pharmaceutical Design Cyclodextrins for Non-Viral Gene and siRNA Delivery
Pharmaceutical Nanotechnology Editorial (Thematic Issue: Signal Transduction of Natural Products for Anticancer Therapy)
Current Signal Transduction Therapy Caveolin Involvement and Modulation in Breast Cancer
Mini-Reviews in Medicinal Chemistry Unraveling Potential Candidate Targets Associated with Expression of p16<sup>INK4a</sup> or p16 Truncated Fragment by Comparative Proteomics Analysis
Current Proteomics NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature
Anti-Cancer Agents in Medicinal Chemistry MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Current Pharmaceutical Design Development of PET Probes for Cancer Imaging
Current Topics in Medicinal Chemistry Advances in Translational Pharmacological Investigations in Identifying and Validating Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology Formulation and Application of Biodegradable Nanoparticles Based Biopharmaceutical Delivery - An Efficient Delivery System
Current Pharmaceutical Design